$27.61
-0.19-0.68%
Pre-Market: 8:04 AM EDT
15 minutes delayed
Genmab reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Genmab using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GMAB | Genmab | $0.30 | $0.32 | — | — | $613.49M | $727.42M | — | — | 08/08/2024 | Get Alert |
GMAB | Genmab | $0.05 | $0.14 | $0.29 | 107.14% | $411.34M | $577.46M | $600.43M | 3.98% | 05/02/2024 | Get Alert |
GMAB | Genmab | $0.12 | $4.02 | $0.36 | -91.04% | $699.51M | $679.55M | $675.05M | -0.66% | 02/14/2024 | Get Alert |
GMAB | Genmab | $0.53 | — | $0.47 | — | $553.75M | $630.48M | $692.70M | 9.87% | 11/07/2023 | Get Alert |
GMAB | Genmab | $0.41 | $0.31 | $0.30 | -2.90% | $453.01M | $618.77M | $613.49M | -0.85% | 08/03/2023 | Get Alert |
GMAB | Genmab | $0.11 | $0.65 | $0.05 | -92.31% | $319.67M | $417.90M | $411.34M | -1.57% | 05/10/2023 | Get Alert |
GMAB | Genmab | $0.17 | $3.18 | $0.12 | -96.23% | $402.80M | $664.17M | $699.51M | 5.32% | 02/22/2023 | Get Alert |
GMAB | Genmab | $0.21 | $1.63 | $0.53 | -67.48% | $366.37M | $475.35M | $553.75M | 16.49% | 11/09/2022 | Get Alert |
GMAB | Genmab | $0.08 | $1.58 | $0.41 | -74.05% | $319.46M | $404.75M | $453.01M | 11.92% | 08/10/2022 | Get Alert |
GMAB | Genmab | $0.27 | — | $0.11 | — | $256.28M | $319.59M | $319.67M | 0.02% | 05/11/2022 | Get Alert |
GMAB | Genmab | $0.14 | — | $0.17 | — | $327.45M | — | $402.80M | — | 02/16/2022 | Get Alert |
GMAB | Genmab | $0.13 | — | $0.21 | — | $270.67M | $319.59M | $366.37M | 14.64% | 11/10/2021 | Get Alert |
GMAB | Genmab | $0.76 | — | $0.08 | — | $804.57M | — | $319.46M | — | 08/11/2021 | Get Alert |
GMAB | Genmab | $0.06 | $0.23 | $0.27 | 17.39% | $131.66M | $207.51M | $256.28M | 23.50% | 05/05/2021 | Get Alert |
GMAB | Genmab | $0.34 | $1.17 | $0.14 | -88.03% | $444.15M | $303.75M | $327.45M | 7.80% | 02/23/2021 | Get Alert |
GMAB | Genmab | $0.12 | $0.91 | $0.13 | -85.71% | $155.98M | $247.63M | $270.67M | 9.30% | 11/04/2020 | Get Alert |
GMAB | Genmab | $0.02 | — | $0.76 | — | $115.61M | — | $804.57M | — | 08/12/2020 | Get Alert |
GMAB | Genmab | — | — | $0.06 | — | — | — | $131.66M | — | 05/06/2020 | Get Alert |
GMAB | Genmab | — | $3.37 | $0.34 | -89.91% | — | $390.98M | $444.15M | 13.60% | 02/19/2020 | Get Alert |
GMAB | Genmab | — | $0.64 | $0.12 | -81.25% | — | $128.75M | $155.98M | 21.15% | 11/06/2019 | Get Alert |
GMAB | Genmab | — | — | $0.02 | — | — | — | $115.61M | — | 08/14/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-02 | $0.29 | $0.14 | 107.1 % |
Dec 2023 | 2024-02-14 | $0.36 | $4.02 | -91.0 % |
Jun 2023 | 2023-08-03 | $0.30 | $0.31 | -2.90 % |
Mar 2023 | 2023-05-10 | $0.05 | $0.65 | -92.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-02 | $600.43M | $577.46M | 3.98 % |
Dec 2023 | 2024-02-14 | $675.05M | $679.55M | -0.66 % |
Sep 2023 | 2023-11-07 | $692.70M | $630.48M | 9.87 % |
Jun 2023 | 2023-08-03 | $613.49M | $618.77M | -0.85 % |
Genmab (GMAB) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
The Actual EPS was $0.29, which beat the estimate of $0.14.
The Actual Revenue was $600.4M, which beat the estimate of $577.5M.
Browse earnings estimates, EPS, and revenue on all stocks.